Javascript must be enabled to continue!
Kinetics of the Antibody Response to Type III Pneumococcal Polysaccharide
View through CrossRef
Abstract
When the number of PFC present in the spleen was measured at 24-hr intervals after immunizing with an optimally immunogenic dose of type III penumococcal polysaccharide (SSS-III), maximal numbers of PFC were attained 4 days after immunization; thereafter, the number of PFC decreased rapidly. By contrast, serum antibody levels, which were measured in the same mice using a Farr test, reached peak values 5 days after immunization and then declined much more sowly than did the number of PFC. Two factors were found to contribute to this disparity. First, experiments conduceted with splenectomized mice showed that extrasplenic antibody synthesis, which began between days 3 and 4 after immunization and peaked on days 6 to 7, accounted for nearly one-third of the total amount of serum antibody produced. Second, the average rate of antibody synthesis by PFC increased through day 6 after immunization and then declined.
Antigen-antibody dissociation tests showed that the avidity of the serum antibody obtained 4 to 7 days after immunization was the same. Moreover, during the same interval, all the antibody detected by the Farr test was of the IgM class. Thus, a change in avidity or class of immunoglobulin after day 5 did not account for the disparity observed. The clearance rate of antibody injected i.v. into nonimmune and immunized mice was studied. The data obtained indicated that accelerated clearance of antibody was occurring prior to day 3 after immunization; however, after day 3 the antibody clearance rate was constant and was the same as that found when antibody was injected into nonimmune mice. These findings affirmed the results of previous studies showing that treadmill neutralization was not important in determining the serum antibody levels present after immunization with an optimally immunogenic dose of SSS-III.
Oxford University Press (OUP)
Title: Kinetics of the Antibody Response to Type III Pneumococcal Polysaccharide
Description:
Abstract
When the number of PFC present in the spleen was measured at 24-hr intervals after immunizing with an optimally immunogenic dose of type III penumococcal polysaccharide (SSS-III), maximal numbers of PFC were attained 4 days after immunization; thereafter, the number of PFC decreased rapidly.
By contrast, serum antibody levels, which were measured in the same mice using a Farr test, reached peak values 5 days after immunization and then declined much more sowly than did the number of PFC.
Two factors were found to contribute to this disparity.
First, experiments conduceted with splenectomized mice showed that extrasplenic antibody synthesis, which began between days 3 and 4 after immunization and peaked on days 6 to 7, accounted for nearly one-third of the total amount of serum antibody produced.
Second, the average rate of antibody synthesis by PFC increased through day 6 after immunization and then declined.
Antigen-antibody dissociation tests showed that the avidity of the serum antibody obtained 4 to 7 days after immunization was the same.
Moreover, during the same interval, all the antibody detected by the Farr test was of the IgM class.
Thus, a change in avidity or class of immunoglobulin after day 5 did not account for the disparity observed.
The clearance rate of antibody injected i.
v.
into nonimmune and immunized mice was studied.
The data obtained indicated that accelerated clearance of antibody was occurring prior to day 3 after immunization; however, after day 3 the antibody clearance rate was constant and was the same as that found when antibody was injected into nonimmune mice.
These findings affirmed the results of previous studies showing that treadmill neutralization was not important in determining the serum antibody levels present after immunization with an optimally immunogenic dose of SSS-III.
Related Results
89Factors associated with pneumococcal nasopharyngeal carriage: a systematic review
89Factors associated with pneumococcal nasopharyngeal carriage: a systematic review
Abstract
Background
Pneumococcal disease is a major contributor to global childhood morbidity and mortality. Pneumococcal carria...
Factors associated with pneumococcal nasopharyngeal carriage: A systematic review
Factors associated with pneumococcal nasopharyngeal carriage: A systematic review
Pneumococcal disease is a major contributor to global childhood morbidity and mortality and is more common in low- and middle-income countries (LMICs) than in high-income countries...
Tamarind seed polysaccharide isolation from tamarind kernel powder by protease enzyme and high-intensity ultrasound
Tamarind seed polysaccharide isolation from tamarind kernel powder by protease enzyme and high-intensity ultrasound
Tamarind seed polysaccharide, xyloglucan (XG), is obtained from Tamarind Kernel Powder (TKP). In food industry, XG is widely used as a thickener, stabilizer, fat replacer, or starc...
Kinetics of the Antibody Response to Type III Pneumococcal Polysaccharide (SSS-III)
Kinetics of the Antibody Response to Type III Pneumococcal Polysaccharide (SSS-III)
Abstract
A simple method was described for the preparation of 125I-labeled type III pneumococcal polysaccharide (SSS-III*) with a high specific radioactivity which r...
Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)
Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)
Introduction
In Canada, pneumococcal vaccination is recommended to all adults aged ≥65 and those <65 who have one or more chronic medical conditions (CMCs). Understanding vaccin...
Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
AbstractBackground. Although it is widely accepted that adults with immunocompromising conditions are at greatly increased risk of pneumococcal infection, the extent of risk among...
Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4
Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4
SUMMARY
In order to define abnormalities of humoral immunity which determine susceptibility to respiratory tract infections in IgA-deficient adults, serum IgG subcla...
Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A
Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A
ABSTRACTBackgroundAcquired haemophilia A (AHA) is an acquired bleeding disorder resulting from autoantibodies against Factor VIII (FVIII). Previous studies have reported difference...

